Cargando…
Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management
Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent decades, and accounts for roughly 40% of all cancers of the small bowel. The majority of SBAs arise in the duodenum and are associated with a dismal prognosis. Surgery remains the mainstay of treatment for local...
Autores principales: | Gelsomino, Fabio, Balsano, Rita, De Lorenzo, Stefania, Garajová, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870676/ https://www.ncbi.nlm.nih.gov/pubmed/35200603 http://dx.doi.org/10.3390/curroncol29020104 |
Ejemplares similares
-
The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
por: Schipilliti, Francesca Matilde, et al.
Publicado: (2021) -
Should patients on levothyroxine therapy be screened for pancreatic cancer?
por: Garajová, Ingrid, et al.
Publicado: (2022) -
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition
por: Medici, Bianca, et al.
Publicado: (2023) -
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
por: Pietri, Elisabetta, et al.
Publicado: (2021) -
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)